Cargando…
In the Era of Systemic Therapy for Hepatocellular Carcinoma Is Transarterial Chemoembolization Still a Card to Play?
SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is a growing healthcare problem, with most of the cases occurring in patients with an underlying chronic liver disease. Transarterial chemoembolization (TACE) is recommended for unresectable tumors, mostly in a palliative setting. Several developments h...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533902/ https://www.ncbi.nlm.nih.gov/pubmed/34680278 http://dx.doi.org/10.3390/cancers13205129 |